CHYM Q1 2026 Earnings Strong EPS Surprise of 2768 Despite Modest Stock Decline CRNX Q1 2026 Earnings NarrowerThanExpected Loss as Crinetics Advances Pipeline BMNR Q1 2026 Earnings EPS Surprise as Company Reports Profitability CTRI Q1 2026 Earnings EPS Surprises Positively Despite Loss Stock Declines Kiora Pharmaceuticals Q1 2026 Earnings EPS Beat Masks Continued PreRevenue Status as Stock Slips Credit Suisse High Yield Credit Fund DHY Slips 14 Support Levels in Focus Nautilus Biotechnology NAUT Pulls Back Key Levels to Watch After 39 Decline Artivion Inc AORT Faces Selling Pressure as Shares Dip Below Key Moving Averages Sila Realty Trust SILA Edges Higher as Price Hovers Near Support Key Levels to Watch Prime Medicine Inc PRME Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Development Phase